News and Press Releases

Check back often as this page will be updated regularly


  • Sarepta Therapeutics Signs Long-term Strategic Investment and License Agreements with Lacerta Therapeutics - Press Release August 8, 2018 at 4:01 PM EDT Sarepta Therapeutics Signs Long-term Strategic Investment and License Agreements with Lacerta Therapeutics, Gaining Rights to Multiple CNS-targeted Gene Therapy programs and Access to Important Gene Therapy Talent and Tools   -- Sarepta expands its presence in gene therapy and broadens its reach with license to up to three new CNS-targeted gene therapy programs, including exclusive rights to Lacerta’s  gene therapy candidate ...READ MORE